CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 3.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,013 | +26.5% | 67,067 | +45.5% | 1.31% | +92.1% |
| Q2 2023 | $619,530 | -18.9% | 46,096 | 0.0% | 0.68% | -27.3% |
| Q1 2023 | $764,272 | -7.9% | 46,096 | +3.4% | 0.94% | +15.7% |
| Q4 2022 | $829,541 | -8.5% | 44,599 | -24.8% | 0.81% | -10.2% |
| Q3 2022 | $907,000 | +14.4% | 59,301 | -47.6% | 0.90% | +23.2% |
| Q2 2022 | $793,000 | -3.6% | 113,077 | +13.8% | 0.73% | +22.6% |
| Q1 2022 | $823,000 | +36.5% | 99,322 | -51.1% | 0.60% | +234.1% |
| Q3 2020 | $603,000 | -35.7% | 203,133 | 0.0% | 0.18% | -42.8% |
| Q2 2020 | $938,000 | +19.9% | 203,133 | 0.0% | 0.31% | -4.6% |
| Q1 2020 | $782,000 | +15.9% | 203,133 | +12.9% | 0.33% | +37.8% |
| Q4 2019 | $675,000 | -28.8% | 179,868 | 0.0% | 0.24% | -34.1% |
| Q3 2019 | $948,000 | – | 179,868 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |